-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Johanna Wyss of the Aarau Children's Oncology Center in Switzerland and others introduced new drugs that can currently be used for GBM in children, and the article was published online in June 2022 in Cancers
——Excerpt from the article chapter
【Ref: Wyss J, et al.
Research background
Glioblastoma (GBM) in children accounts for 2.
Investigators systematically searched PubMed and Embase data for relevant English-language literature published between 2010 and 2021, including randomized controlled trials, cohort studies, and case series
Results of the study
The study selected six from 1122 clinical study reports as results
The findings suggest that the efficacy of the drug in treating GBM in children is unclear, and there are currently no new drugs that can significantly improve overall or progression-free survival in children with GBM